Drs. Lajos Pusztai (Medicine-Oncology), Richard Kibbey (Medicine-Endocrinology, Physiology), and Jesse Rinehart: exploiting metabolic vulnerabilities to enhance breast cancer treatment in vivo and in vitro.
Dr. Andrew Wang (Medicine-Rheumatology, Immunobiology): understanding metabolic reprogramming in stress states.
Dr. Valentina Greco (Genetics): metabolic reprogramming in skin development.
Dr. Yajaira Suarez (Comparative Medicine, Pathology): modulation of tumor glucose utilization with endothelial cell manipulations.
Drs. Xiaoyong Yang (Comparative Medicine) and Siyuan (Steven) Wang (Genetics, Cell Biology): constructing a multidimensional functional map of the NASH-cirrhosis-hepatocellular carcinoma transition.
Dr. Lohith Gowda: characterizing and enhancing immunometabolic reprogramming following stem cell transplant for hematologic malignancy (possible human study in the future).